AstraZeneca PLC (Mexico) Today

AZNN Stock  MXN 1,165  24.99  2.10%   

Performance

1 of 100

 
Weak
 
Strong
Weak

Odds Of Distress

Less than 46

 
High
 
Low
About Average
AstraZeneca PLC is trading at 1165.00 as of the 19th of April 2024; that is -2.1 percent decrease since the beginning of the trading day. The stock's open price was 1189.99. AstraZeneca PLC has 46 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. Equity ratings for AstraZeneca PLC are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 20th of March 2024 and ending today, the 19th of April 2024. Click here to learn more.
AstraZeneca PLC discovers, develops, manufactures, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, infection, neuroscience, and gastroenterology worldwide. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. The company has 3.1 B outstanding shares. More on AstraZeneca PLC

Moving against AstraZeneca Stock

  0.43ABBV AbbVie Inc Earnings Call This WeekPairCorr
AstraZeneca PLC cannot be verified against its exchange. It appears that AstraZeneca PLC is not available for investing at the moment. Please verify the symbol is currently traded on Mexican Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Refresh

AstraZeneca Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. AstraZeneca PLC's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding AstraZeneca PLC or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEOPascal Soriot
Business ConcentrationDrug Manufacturers—General, Healthcare (View all Sectors)
AstraZeneca PLC (AZNN) is traded on Mexican Exchange in Mexico and employs 48 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 4.04 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AstraZeneca PLC's market, we take the total number of its shares issued and multiply it by AstraZeneca PLC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. AstraZeneca PLC operates under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 3.1 B outstanding shares. AstraZeneca PLC has accumulated about 15.63 B in cash with 9.81 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.96.
Check AstraZeneca PLC Probability Of Bankruptcy

AstraZeneca Stock Against Markets

Picking the right benchmark for AstraZeneca PLC stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in AstraZeneca PLC stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for AstraZeneca PLC is critical whether you are bullish or bearish towards AstraZeneca PLC at a given time. Please also check how AstraZeneca PLC's historical prices are related to one of the top price index indicators.

Try Other Suggestions

A Agilent TechnologiesCompany
AFGD American Financial GroupCompany
ACP Aberdeen Income CreditFund
AK AKETF
AMZ Alerian MLP IndexIndex
AE AECryptocurrency
A9890AAA8 USA9890AAA81Corporate Bond
ALIUSD Aluminum FuturesCommodity

Be your own money manager

Our tools can tell you how much better you can do entering a position in AstraZeneca PLC without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Risk-Return Analysis Now

   

Risk-Return Analysis

View associations between returns expected from investment and the risk you assume
All  Next Launch Module

AstraZeneca PLC Corporate Directors

AstraZeneca PLC corporate directors refer to members of an AstraZeneca PLC board of directors. The board of directors generally takes responsibility for the AstraZeneca PLC's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of AstraZeneca PLC's board members must vote for the resolution. The AstraZeneca PLC board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Marc DunoyerChief Financial Officer, Executive DirectorProfile
Sherilyn McCoyNon-Executive Independent DirectorProfile
Genevieve BergerNon-Executive Independent DirectorProfile
Nazneen RahmanNon-Executive Independent DirectorProfile

How to buy AstraZeneca Stock?

Before investing in AstraZeneca PLC, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in AstraZeneca PLC. To buy AstraZeneca PLC stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of AstraZeneca PLC. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase AstraZeneca PLC stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located AstraZeneca PLC stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased AstraZeneca PLC stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as AstraZeneca PLC, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.

Already Invested in AstraZeneca PLC?

The danger of trading AstraZeneca PLC is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of AstraZeneca PLC is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than AstraZeneca PLC. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile AstraZeneca PLC is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Complementary Tools for AstraZeneca Stock analysis

When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
CEOs Directory
Screen CEOs from public companies around the world
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.